ZA934021B - Treatment of bovine mastitis - Google Patents

Treatment of bovine mastitis

Info

Publication number
ZA934021B
ZA934021B ZA934021A ZA934021A ZA934021B ZA 934021 B ZA934021 B ZA 934021B ZA 934021 A ZA934021 A ZA 934021A ZA 934021 A ZA934021 A ZA 934021A ZA 934021 B ZA934021 B ZA 934021B
Authority
ZA
South Africa
Prior art keywords
treatment
bovine mastitis
mastitis
metritis
composition
Prior art date
Application number
ZA934021A
Other languages
English (en)
Inventor
A H J Rajamannan
Original Assignee
Agro K Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agro K Corp filed Critical Agro K Corp
Publication of ZA934021B publication Critical patent/ZA934021B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Insulating Materials (AREA)
  • Disintegrating Or Milling (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA934021A 1992-07-14 1993-12-08 Treatment of bovine mastitis ZA934021B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/913,034 US5260341A (en) 1992-07-14 1992-07-14 Product and process for treating bovine mastitis and bovine metritis

Publications (1)

Publication Number Publication Date
ZA934021B true ZA934021B (en) 1995-01-16

Family

ID=25432872

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934021A ZA934021B (en) 1992-07-14 1993-12-08 Treatment of bovine mastitis

Country Status (13)

Country Link
US (1) US5260341A (xx)
EP (1) EP0579488B1 (xx)
JP (1) JPH06256176A (xx)
AT (1) ATE143804T1 (xx)
AU (1) AU676473B2 (xx)
CA (1) CA2097740C (xx)
DE (1) DE69305267T2 (xx)
DK (1) DK0579488T3 (xx)
ES (1) ES2095578T3 (xx)
GR (1) GR3022030T3 (xx)
MX (1) MX9304185A (xx)
NZ (1) NZ248135A (xx)
ZA (1) ZA934021B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449517A (en) * 1993-11-22 1995-09-12 Fitzjarrell; Edwin A. Method and formulation for eliminating fleas on animals
US5622123A (en) * 1995-08-10 1997-04-22 Aqua Heat Technology, Inc. Process and apparatus for killing soil pathogens
US5846543A (en) * 1995-10-24 1998-12-08 Hassler; Mark A. Bovine mastitis treatment
DE19631037C2 (de) * 1996-08-01 2002-12-05 Boehringer Ingelheim Vetmed Neue Wirkstoffkombinationen aus bacterizid wirkenden Substanzen mit terpenhaltigen Pflanzenextrakten
GT199800140A (es) * 1997-09-12 2000-02-29 Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimientos para fabricarla.
EP1054681B1 (de) * 1998-02-02 2003-05-07 Boehringer Ingelheim Vetmedica Gmbh Verwendung von wirkstoffkombinationen aus antibiotika und terpenhaltigen pflanzenextrakten in der tiermedizin
NL1014260C2 (nl) * 2000-02-02 2001-08-03 Lely Entpr Ag Inrichting voor het detecteren van fysische afwijkingen in melk.
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
RU2454972C2 (ru) * 2010-03-19 2012-07-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Казанская государственная академия ветеринарной медицины им. Н.Э. Баумана" Способ лечения синдрома метрит-мастит-агалактия (мма) у свиноматок
CN104095900A (zh) * 2014-07-11 2014-10-15 上海育生堂科技有限公司 一种用于通乳的可清热解毒、排毒透脓的中药酒膏药
CN104721393A (zh) * 2015-03-24 2015-06-24 臧兰恕 一种治疗热毒炽盛型乳痈的中药组合物
RU2699723C1 (ru) * 2019-01-14 2019-09-09 Общество с ограниченной ответственностью "Агровейт" Препарат "райдо" для профилактики и лечения маститов у коров и способ его получения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904780A (en) * 1973-05-30 1975-09-09 Suntory Ltd Method for giving and increasing the flavor resembling to dairy product
US4320149A (en) * 1979-10-15 1982-03-16 Minnesota Mining And Manufacturing Company Use of fluorinated beta-diketones as antiplaque agents
JPS5929618A (ja) * 1982-08-11 1984-02-16 T Hasegawa Co Ltd 虫歯防止剤
US5147652A (en) * 1990-07-03 1992-09-15 Cell Research Corporation Autobiotics and their use in eliminating nonself cells in vivo

Also Published As

Publication number Publication date
AU4148693A (en) 1994-01-20
DK0579488T3 (da) 1996-11-18
AU676473B2 (en) 1997-03-13
CA2097740C (en) 2002-03-26
EP0579488A1 (en) 1994-01-19
MX9304185A (es) 1994-04-29
US5260341A (en) 1993-11-09
GR3022030T3 (en) 1997-03-31
CA2097740A1 (en) 1994-01-15
DE69305267D1 (de) 1996-11-14
JPH06256176A (ja) 1994-09-13
DE69305267T2 (de) 1997-03-13
NZ248135A (en) 1995-10-26
ES2095578T3 (es) 1997-02-16
EP0579488B1 (en) 1996-10-09
ATE143804T1 (de) 1996-10-15

Similar Documents

Publication Publication Date Title
EP0746202A4 (en) COMPOSITION CONTAINING A PHARMACEUTICALLY ACTIVE ANTI-OXIDANT AND METHOD FOR USE IN THE PREVENTION AND TREATMENT OF RESTENOSIS AFTER ANGIOPLASTY
ZA911876B (en) Method and composition for increased skin concentration of active agents by iontophoresis
GR3023289T3 (en) Analgesic agent and its use
ZA934021B (en) Treatment of bovine mastitis
GB8604528D0 (en) Therapeutic agents
GR3031691T3 (en) Composition and method for preventing and treating inflammation with immunoglobulin a
GB2211192B (en) Composition and process for the treatment and care of the hair
PL340679A1 (en) Application of a mixture of diole and alpha-hydroxyacid in treating
EP0133554A3 (en) Monohydroxy-benzoyl peroxide and compositions for treating acne
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
MY111755A (en) Use of 4'-iodo-4'- deoxydoxorubicin for the treatment of amyloidosis.
TW253837B (xx)
AU3039789A (en) Active substance for treating changes in the skin and mucous membranes
EP0673646A3 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen.
EP0092386A3 (en) Hydantoin therapeutic agents
UA7413A1 (uk) Спосіб лікування псоріазу
AU2492892A (en) The device for treatment and prophylaxis of mastitis in animals
DE3562997D1 (en) Non-return seal for use in the treatment of wood, process for positioning and closing the seal's bung
EP0267402A3 (en) Use of follicle regulatory protein for the production of a therapeutic agent for the treatment of neoplasm of gonadal origin
RO105585B1 (ro) Compozitie medicamentoasa folosita in tratamentul ulcerului de gamba
AU1104888A (en) Cosmetic agent and composition for skin treatment
IT1265055B1 (it) Uso della 4'-desossi-4'-iododoxorubicina per il trattamento della al amiloidosi